2-(Tributylstannyl)pyrazine → HCID 136404173, 화합물

반응식

[CH2:1]([O:5][C:6]([C:8]1[N:13]=[C:12](Br)[C:11]2[C:15]([CH3:18])=[N:16][S:17][C:10]=2[C:9]=1[OH:19])=[O:7])[CH2:2][CH2:3][CH3:4].C([Sn](CCCC)(CCCC)[C:25]1[CH:30]=[N:29][CH:28]=[CH:27][N:26]=1)CCC>>[CH2:1]([O:5][C:6]([C:8]1[N:13]=[C:12]([C:25]2[CH:30]=[N:29][CH:28]=[CH:27][N:26]=2)[C:11]2[C:15]([CH3:18])=[N:16][S:17][C:10]=2[C:9]=1[OH:19])=[O:7])[CH2:2][CH2:3][CH3:4]

참가 물질

반응물 2

HCID 27373162-(Tributylstannyl)pyrazine

HCID 86649354HCID 86649354, 화합물

생성물 1

HCID 136404173HCID 136404173, 화합물

실험 절차

The title compound was synthesized in analogy Example 3 from 4-bromo-7-hydroxy-3-methyl-isothiazolo[4,5-c]pyridine-6-carboxylic acid butyl ester and 2-(tributylstannyl)pyrazine: MS (m/z) 345.2 (M+1)+.

출처 및 근거

ORD 기록: ord-2cd1da1cc16a4056a995eb2f5abc8926
출처 데이터셋: uspto-grants-2016_07
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US09387200B2

반응 노트

불러오는 중…